World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
27165
World Ranking
17901
National Ranking
8930

Overview

Tito R. Mendoza is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research contributions span the field of Medicine with a focus on Oncology, Pulmonary and Respiratory Medicine, Genetics, Economics and Econometrics, and Pediatrics, Perinatology and Child Health.

Their main fields of study include:

  • Medicine

Subfields they have extensively contributed to are:

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Genetics
  • Economics and Econometrics
  • Pediatrics, Perinatology and Child Health

The scientist's work largely addresses topics related to cancer research and treatment, including:

  • Cancer survivorship and care
  • Glioma Diagnosis and Treatment
  • Childhood Cancer Survivors' Quality of Life
  • Cancer-related cognitive impairment studies
  • Health Systems, Economic Evaluations, Quality of Life
  • Brain Metastases and Treatment
  • Palliative Care and End-of-Life Issues

Tito R. Mendoza has published multiple papers in well-known venues. Frequent publication outlets for their work include:

  • Neuro-Oncology
  • Journal of Clinical Oncology
  • UNC Libraries
  • Cancer Research
  • Clinical Trials

Some recent papers include:

  • Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE), 2020, Clinical Trials
  • Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report, 2020, The Lancet Oncology
  • Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas, 2021, Clinical Cancer Research
  • Shared Decision-Making for Lung Cancer Screening, 2021, CHEST Journal
  • Patient-Reported Symptom and Functioning Status during the First 12 Months after Chimeric Antigen Receptor T Cell Therapy for Hematologic Malignancies, 2021, Transplantation and Cellular Therapy

Frequent co-authors in their research include:

  • Terri S. Armstrong
  • Elizabeth Vera
  • Charles S. Cleeland
  • Mark R. Gilbert
  • Marta Peñas-Prado

Best Publications

  • The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory.

    Tito R. Mendoza;X. Shelley Wang;Charles S. Cleeland;Marilyn Morrissey

  • When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function.

    Ronald C. Serlin;Tito R. Mendoza;Yoshio Nakamura;Katherine R. Edwards

  • Assessing symptom distress in cancer patients: The M. D. Anderson Symptom Inventory

    Charles S. Cleeland;Tito R. Mendoza;Xin Shelley Wang;Chyi Chou

  • Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain.

    San Keller;Carla M. Bann;Sheri L. Dodd;Jeff Schein

  • Development of the National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

    Ethan Basch;Ethan Basch;Bryce B. Reeve;Sandra A. Mitchell;Steven B. Clauser

  • Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

    Amylou C. Dueck;Tito R. Mendoza;Sandra A. Mitchell;Bryce B. Reeve

  • Reliability and validity of a modified Brief Pain Inventory short form in patients with osteoarthritis

    Tito R Mendoza;Tracy Mayne;Dale Rublee;Charles Cleeland

  • Minority cancer patients and their providers: pain management attitudes and practice.

    Karen O. Anderson;Tito R. Mendoza;Vicente Valero;Stephen P. Richman

  • The Norwegian Brief Pain Inventory Questionnaire: Translation and Validation in Cancer Pain Patients

    Pål Klepstad;Jon Håvard Loge;Petter C Borchgrevink;Tito R Mendoza

  • Prevalence and characteristics of moderate to severe fatigue: A multicenter study in cancer patients and survivors

    Xin Shelley Wang;Fengmin Zhao;Michael J. Fisch;Ann M. O'Mara

  • The Chinese version of the Brief Pain Inventory (BPI-C) : its development and use in a study of cancer pain

    Xin Shelley Wang;Tito R. Mendoza;Shuo Zheng Gao;Charles S. Cleeland

  • Automated Symptom Alerts Reduce Postoperative Symptom Severity After Cancer Surgery: A Randomized Controlled Clinical Trial

    Charles S. Cleeland;Xin Shelley Wang;Qiuling Shi;Tito R. Mendoza

  • Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy

    Lajos Pusztai;Tito R Mendoza;James M. Reuben;Monica M. Martinez

  • Cancer pain management among underserved minority outpatients: perceived needs and barriers to optimal control.

    Karen O. Anderson;Stephen P. Richman;Judith Hurley;Guadalupe Palos

  • The symptom burden of cancer: Evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study.

    Charles S. Cleeland;Fengmin Zhao;Victor T. Chang;Jeff A. Sloan

  • Measuring head and neck cancer symptom burden: The development and validation of the M. D. Anderson symptom inventory, head and neck module†

    David Rosenthal;Tito R Mendoza;Mark S Chambers;Joshua A. Asper

  • Prospective, Observational Study of Pain and Analgesic Prescribing in Medical Oncology Outpatients With Breast, Colorectal, Lung, or Prostate Cancer

    Michael J. Fisch;Ju Whei Lee;Matthias Weiss;Lynne I. Wagner

  • Dimensions of the impact of cancer pain in a four country sample: new information from multidimensional scaling

    Charles S. Cleeland;Yoshio Nakamura;Tito R. Mendoza;Katherine R. Edwards

  • Assessing symptom distress in cancer patients. The M.D. Anderson symptom inventory. (The University of Texas M. D. Anderson Cancer Center, Houston, Texas) Cancer 2000;89:1634–1646.

    Charles S. Cleeland;Tito R. Mendoza;Xin Shelley Wang;Chyi Chou

  • When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function.

    R E Serlin;Rodrigo Y. M. Nakamura;Tito R Mendoza;Andrew K. Edwards

Frequent Co-Authors

Charles S. Cleeland
Charles S. Cleeland The University of Texas MD Anderson Cancer Center
David I. Rosenthal
David I. Rosenthal The University of Texas MD Anderson Cancer Center
Adam S. Garden
Adam S. Garden The University of Texas MD Anderson Cancer Center
Ethan Basch
Ethan Basch University of North Carolina at Chapel Hill
Mark R. Gilbert
Mark R. Gilbert National Institutes of Health
Bryce B. Reeve
Bryce B. Reeve Duke University
Charles Lu
Charles Lu The University of Texas MD Anderson Cancer Center
Sergio Giralt
Sergio Giralt Memorial Sloan Kettering Cancer Center
Valen E. Johnson
Valen E. Johnson Texas A&M University
Deborah Schrag
Deborah Schrag Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always begin with traditional in-person medical school. Today, there are many online pathways that can help you enter the healthcare field or advance your current career. One popular option is medical billing and coding, which offers a flexible entry point into healthcare administration. Prospective students should carefully consider the medical billing and coding certification cost to ensure the program fits their budget and career goals.

For those interested in patient care, nursing offers a variety of online routes—from LPN and RN degrees to advanced practice roles. If affordability is a concern, research the most affordable online nurse practitioner programs to determine your best path. Many students begin by enrolling in nursing school online, balancing coursework with existing commitments.

For experienced nurses aiming for leadership, academia, or specialized research, pursuing an online nursing doctorate can open doors to the highest levels of practice and impact. Whichever route you choose, online degrees in healthcare continue to expand access and flexibility for tomorrow’s medical professionals.

Best Scientists Citing Tito R. Mendoza

Trending Scientists

Recently Published Articles